SEC 13F Intelligence

Ghost Tree Capital, LLC / ACAD

Ghost Tree Capital, LLC’s Acadia Pharmaceuticals Inc Position

Does Ghost Tree Capital, LLC own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 225.0K shares worth $4M in Q2 2024; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$4M
Q2 2024
Shares
225.0K
% of Portfolio
+1.14%
Quarters Held
8
position exited

Position History ACAD

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $24MQ1 ’19Q2 ’19: $20MQ2 ’19Q2 ’20: $8MQ2 ’20Q3 ’23: $2MQ3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $4MQ1 ’24Q2 ’24: $4MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024225.0K$4M+1.14%
Q1 2024225.0K$4M+1.15%
Q4 202350.0K$2M+0.51%
Q3 202380.0K$2M+0.55%
Q2 2020165.0K$8M+2.11%
Q2 2019750.0K$20M+4.20%
Q1 2019900.0K$24M+6.55%
Q4 2018125.0K$2M+0.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of ACAD.